-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 4, the Jiangsu Provincial Public Resource Trading Center issued a notice to withdraw the drugs listed on the Internet.
The notice showed that 15 drugs, including Liganlong Granules, Shuanghuanglian Oral Liquid, and Obucaine Hydrochloride Eye Drops, were to be withdrawn from the Internet
.
The original text is as follows: Notice of the Provincial Public Resource Exchange Center on Publicizing the Proposed Revocation of Drugs on the Internet All related drug manufacturers: According to the "Implementation Opinions of the Jiangsu Provincial Medical Security Bureau on Further Promoting the Sunshine Procurement of Drugs" (Su Yibaofa [202164]), " The Jiangsu Provincial Medical Security Bureau's Letter on Announcement of Drugs Eligible for Withdrawal from the Internet (Su Yibaohan [2022] No.
51) has been reviewed and confirmed according to relevant procedures, and the drugs to be withdrawn from the Internet are now announced (see details for details).
attachment)
.
The publicity period is from March 4, 2022 to March 10, 17:00
.
If there is any objection, the enterprise must appeal through the Jiangsu Provincial Public Resource Trading Platform (Drug Classified Procurement-Other-Revocation of the Online Appeal (202203)) within the publicity period, and submit relevant certification materials
.
The notice showed that 15 drugs, including Liganlong Granules, Shuanghuanglian Oral Liquid, and Obucaine Hydrochloride Eye Drops, were to be withdrawn from the Internet
.
The original text is as follows: Notice of the Provincial Public Resource Exchange Center on Publicizing the Proposed Revocation of Drugs on the Internet All related drug manufacturers: According to the "Implementation Opinions of the Jiangsu Provincial Medical Security Bureau on Further Promoting the Sunshine Procurement of Drugs" (Su Yibaofa [202164]), " The Jiangsu Provincial Medical Security Bureau's Letter on Announcement of Drugs Eligible for Withdrawal from the Internet (Su Yibaohan [2022] No.
51) has been reviewed and confirmed according to relevant procedures, and the drugs to be withdrawn from the Internet are now announced (see details for details).
attachment)
.
The publicity period is from March 4, 2022 to March 10, 17:00
.
If there is any objection, the enterprise must appeal through the Jiangsu Provincial Public Resource Trading Platform (Drug Classified Procurement-Other-Revocation of the Online Appeal (202203)) within the publicity period, and submit relevant certification materials
.
